semaglutide diabetes trial Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 at high cardiovascular risk treated with experience more stable kidney function compared with placebo Positive results in trial testing

In 2025, the global bone cement market was valued at Autologous Cell Therapy Market Outlook USD 9.31B-USD 54.83B How Is the Autologous Cell Therapy Market Redefining the Future of Precision Medicine

Two days later, Hims & Hers revealed it also bought a U.S.-based peptide facility based in California to expand its domestic supply chain

NICE guidance now recommends early consideration of SGLT2 inhibitors for people with established cardiovascular disease, heart failure, or chronic kidney disease

Food and Drug Administration is cracking down on telehealth companies for making false and misleading claims about compounded versions of popular weight loss drugs, GLP-1s